CliffBio
small molecule

WIGRETTES

ERGOTAMINE TARTRATE

Loss of exclusivity—loss of exclusivity
CompanyOrganon →See this company's full patent-cliff portfolio

Drug detail

Brand nameWIGRETTES
Active ingredientERGOTAMINE TARTRATE
Strength2MG
Dosage formTABLET
RouteSUBLINGUAL
ModalitySmall molecule
FDA approvalJuly 1982
Marketing statusDISCN

More from Organon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

WIGRETTES patent cliff — loss of exclusivity — | CliffBio